Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AWT020 in Advanced Solid Tumors
NCT07822919Phase 1Recruiting
- Sponsor
- Anwita Biosciences
- Start
- Sep 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of AWT020 in solid tumor, sponsored by Anwita Biosciences. Primary endpoints: Adverse Events up to 30 months, Serious Adverse Events up to 30 months and 3 more. Started Sep 2026; status: recruiting.
02
Drugs
AWT020
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07822919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07822919.